DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,875,438 | +1.2% | 31,743 | -2.1% | 0.07% | +11.5% |
| Q2 2023 | $7,781,280 | -6.5% | 32,422 | -1.8% | 0.06% | -12.9% |
| Q1 2023 | $8,324,125 | -2.2% | 33,027 | +3.0% | 0.07% | -6.7% |
| Q4 2022 | $8,510,958 | +55.2% | 32,066 | +51.0% | 0.08% | +50.0% |
| Q3 2022 | $5,483,000 | +1.6% | 21,230 | -0.3% | 0.05% | +16.3% |
| Q2 2022 | $5,396,000 | -35.3% | 21,284 | -25.1% | 0.04% | -14.0% |
| Q1 2022 | $8,335,000 | -15.4% | 28,415 | -5.1% | 0.05% | -2.0% |
| Q4 2021 | $9,852,000 | +28.6% | 29,944 | +19.0% | 0.05% | +10.9% |
| Q3 2021 | $7,661,000 | +16.4% | 25,162 | +2.6% | 0.05% | +17.9% |
| Q2 2021 | $6,581,000 | +29.5% | 24,524 | +8.6% | 0.04% | +18.2% |
| Q1 2021 | $5,083,000 | -9.4% | 22,582 | -10.6% | 0.03% | -5.7% |
| Q4 2020 | $5,608,000 | +14.4% | 25,247 | +10.9% | 0.04% | 0.0% |
| Q3 2020 | $4,901,000 | -32.8% | 22,763 | -44.8% | 0.04% | -37.5% |
| Q2 2020 | $7,292,000 | +201.7% | 41,242 | +136.2% | 0.06% | +133.3% |
| Q1 2020 | $2,417,000 | -67.5% | 17,459 | -64.0% | 0.02% | -57.1% |
| Q4 2019 | $7,441,000 | +70.9% | 48,490 | +60.9% | 0.06% | +60.0% |
| Q3 2019 | $4,353,000 | -21.2% | 30,140 | -22.0% | 0.04% | -22.2% |
| Q2 2019 | $5,524,000 | -13.0% | 38,655 | -19.6% | 0.04% | -13.5% |
| Q1 2019 | $6,350,000 | -8.2% | 48,094 | -28.3% | 0.05% | -11.9% |
| Q4 2018 | $6,919,000 | -47.4% | 67,091 | -44.5% | 0.06% | -31.4% |
| Q3 2018 | $13,143,000 | +35.6% | 120,957 | +23.2% | 0.09% | +32.3% |
| Q2 2018 | $9,692,000 | -88.4% | 98,198 | -88.5% | 0.06% | -68.1% |
| Q1 2018 | $83,534,000 | +2.3% | 853,179 | -3.1% | 0.20% | +5.2% |
| Q4 2017 | $81,686,000 | +9.2% | 880,069 | +0.9% | 0.19% | +10.2% |
| Q3 2017 | $74,836,000 | -3.9% | 872,428 | -5.4% | 0.18% | -14.6% |
| Q2 2017 | $77,848,000 | +11.8% | 922,461 | +13.3% | 0.21% | +9.0% |
| Q1 2017 | $69,613,000 | +4.1% | 813,866 | -5.2% | 0.19% | -1.0% |
| Q4 2016 | $66,859,000 | +15.2% | 858,913 | +16.1% | 0.19% | +6.1% |
| Q3 2016 | $58,013,000 | +17.3% | 740,060 | +51.1% | 0.18% | +16.1% |
| Q2 2016 | $49,478,000 | -10.7% | 489,884 | -16.1% | 0.16% | -11.4% |
| Q1 2016 | $55,380,000 | -4.9% | 583,811 | -6.9% | 0.18% | +3.6% |
| Q4 2015 | $58,230,000 | +23.7% | 626,941 | +13.5% | 0.17% | +16.6% |
| Q3 2015 | $47,085,000 | -6.9% | 552,596 | -6.5% | 0.14% | +16.0% |
| Q2 2015 | $50,562,000 | +0.9% | 590,729 | +0.1% | 0.12% | +5.0% |
| Q1 2015 | $50,097,000 | +6.0% | 590,063 | +7.0% | 0.12% | 0.0% |
| Q4 2014 | $47,271,000 | +9.7% | 551,512 | -2.8% | 0.12% | +15.5% |
| Q3 2014 | $43,109,000 | +0.7% | 567,383 | +4.3% | 0.10% | -4.6% |
| Q2 2014 | $42,828,000 | +10.6% | 543,924 | +5.3% | 0.11% | -1.8% |
| Q1 2014 | $38,732,000 | +2.3% | 516,399 | +5.3% | 0.11% | -4.3% |
| Q4 2013 | $37,866,000 | +23.9% | 490,490 | +11.3% | 0.12% | +4.5% |
| Q3 2013 | $30,550,000 | +16.7% | 440,730 | +6.5% | 0.11% | 0.0% |
| Q2 2013 | $26,185,000 | – | 413,663 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |